Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Adjuvant effects on antibody titreBarry Walker, Ian Feavers
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2010
Functional antibody assaysIan Feavers, Barry Walker
Vaccine|May 27, 2004
Scientific challenges for the quality control and production of group C meningococcal conjugate vaccinesLuis Jódar, Elwyn Griffiths, Ian Feavers
Toxins|July 20, 2019
Assays for Determining Pertussis Toxin Activity in Acellular Pertussis VaccinesKevin Markey, Catpagavalli Asokanathan, Ian Feavers
ALTEX|December 3, 2015
Limitations of the rabbit pyrogen test for assessing meningococcal OMV based vaccinesCaroline Vipond, Lucy Findlay, Ian Feavers, et al.
Expert Review of Vaccines|September 4, 2014
Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assaysDorothy Xing, Kevin Markey, Rose Gaines Das, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 20, 2012
WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3-4 October 2011Ian Feavers, Elwyn Griffiths, Maria Baca-Estrada, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 11, 2025
Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological productsIan Feavers, Dianliang Lei, Catherine Milne, et al.
Proteomics|January 13, 2009
Analysis of outer membrane porin complexes of Neisseria meningitidis in wild-type and specific knock-out mutant strainsJuan Marzoa, Ana Abel, Sandra Sánchez, et al.
The Lancet. Child & Adolescent Health|September 1, 2018
Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance studyPhilip Bryan, Suzie Seabroke, Jenny Wong, et al.
Pageof 3